25.09.2008
BrainsGate launches ImpACT-24
BrainsGate is launching its pivotal trial for acute ischemic stroke at the World Stroke Congress in Vienna. The trial, called ImpACT-24 (Implant for Augmentation of CBF Trial in a 24 hour window), is designed as a multi-center, multi-national RCT. Principal investigators from participating sites are invited to participate in the trial launch dinner on September 25, in the Palais Daun Kinsky. |
|
|
|
October 13, 2009
ImpACT-24 at Central DuPage Hosital
National Investigational Trial for Emergency Stroke Care At CDH: One Illinois Hospital Tests New Device That May Reverse Brain Damage Up to 24 Hours After Stroke > full story
September 25, 2008
BrainsGate launches ImpACT-24
ImpACT-24 is a randomized, sham-controlled, double blind study to test the safety and efficacy of BrainsGate's ISS for treatment of acute ischemic stroke victims in a 24 hour window > full story
|
Login
